Details
Stereochemistry | RACEMIC |
Molecular Formula | C18H22ClNO |
Molecular Weight | 303.826 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCOC(C)(C1=CC=CC=C1)C2=CC=C(Cl)C=C2
InChI
InChIKey=KKHPNPMTPORSQE-UHFFFAOYSA-N
InChI=1S/C18H22ClNO/c1-18(21-14-13-20(2)3,15-7-5-4-6-8-15)16-9-11-17(19)12-10-16/h4-12H,13-14H2,1-3H3
Molecular Formula | C18H22ClNO |
Molecular Weight | 303.826 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionCurator's Comment: Description was created based on several sources, including
https://www.drugs.com/international/systral.html
http://en.pharmacodia.com/web/drug/1_10746.html
Curator's Comment: Description was created based on several sources, including
https://www.drugs.com/international/systral.html
http://en.pharmacodia.com/web/drug/1_10746.html
Chlorphenoxamine is an antihistamine and anticholinergic used as an antipruritic and was formerly used in the sympathomimetic treatment of parkinsonism. Histamine receptor H1 antagonist. Chlorphenoxamine is used to treat Allergic conditions, it is reported as an ingredient of Systral in Germany, Malta, Portugal, Thailand, Turkey.
CNS Activity
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Antimycobacterial antihistaminics]. | 1989 Aug |
|
Simultaneous spectrophotometric determination of chlorphenoxamine hydrochloride and caffeine in a pharmaceutical preparation using first derivative of the ratio spectra and chemometric methods. | 2002 May 15 |
|
[Significance of chromatographic methods coupled with mass spectrometry for identification of drugs for medico-legal purposes exemplified by chlorphenoxamine]. | 2003 Apr-Jun |
|
Simultaneous determination of caffeine, 8-chlorotheophylline, and chlorphenoxamine hydrochloride in ternary mixtures by ratio-spectra zero-crossing first-derivative spectrophotometric and chemometric methods. | 2005 Jul-Aug |
|
Aspirin-induced unilateral angioedema of the tongue. | 2006 May |
|
Spectrophotometric determination of some histamine H1-antagonists drugs in their pharmaceutical preparations. | 2008 Jan |
|
In vitro antibacterial activity of some systemic and topical antihistaminic preparations. | 2009 Dec 1 |
Patents
Sample Use Guides
Topical/Cutaneous
Allergic conditions
Adult: Apply when required several times daily.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20003827
Unknown
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:05:26 GMT 2023
by
admin
on
Fri Dec 15 17:05:26 GMT 2023
|
Record UNII |
3UVD77BP8R
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29704
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
||
|
WHO-VATC |
QR06AA06
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
||
|
WHO-VATC |
QR06AA56
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
||
|
WHO-ATC |
D04AA34
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
||
|
WHO-VATC |
QD04AA34
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
||
|
WHO-ATC |
R06AA56
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
||
|
NCI_THESAURUS |
C29578
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
||
|
WHO-ATC |
R06AA06
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB06204MIG
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
PRIMARY | |||
|
100000081872
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
PRIMARY | |||
|
885
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
PRIMARY | |||
|
3UVD77BP8R
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
PRIMARY | |||
|
m3457
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
PRIMARY | Merck Index | ||
|
C81131
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
PRIMARY | |||
|
DTXSID5022805
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
PRIMARY | |||
|
DB09007
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
PRIMARY | |||
|
617
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
PRIMARY | |||
|
C100100
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
PRIMARY | |||
|
6475
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
PRIMARY | |||
|
20881
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
PRIMARY | RxNorm | ||
|
CHLORPHENOXAMINE
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
PRIMARY | |||
|
77-38-3
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110774
Created by
admin on Fri Dec 15 17:05:26 GMT 2023 , Edited by admin on Fri Dec 15 17:05:26 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |